News about Biotechnology

Alembic Pharma gets US FDA approval for generic Levitra tablets

Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) vardenafil hydrochloride tablets, 2.5 mg (base), 5 mg (base), 10 mg (base), and 20 mg (base)

Biotechnology | 06/08/2020 | By Darshana |  480

FDA Revises Draft Guidance on Animal Drugs Intended for Minor Uses and Minor Species

The FDA encourages the development of safe and effective products to improve the health and well-being of all animals, including those for which there are limited options available because of the relatively small market they represent

Biotechnology | 20/07/2020 | By Darshana |  466

NRDC invites proposals for COVID-19 technologies for scaling up and validation

The National Research Development Corporation (NRDC), under the Department of Science and Technology (DST), has invited proposals from the innovators under its Department of Scientific and Industrial Research (DSIR) grants-in-aid promotional programme for development of technologies for commercialization (PDTC) for up-scaling the COVID-19

Biotechnology | 17/07/2020 | By Darshana |  306

GSK collaborates with Medicago to develop novel adjuvanted COVID-19 candidate vaccine

GSK and Medicago, a biopharmaceutical company, announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago's recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK's pandemic adjuvant system

Biotechnology | 09/07/2020 | By Darshana |  399

Thermo Fisher Scientific launches serology testing kit for infectious diseases

Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific MAS Omni Infectious Disease quality control sets for monitoring serological assays for analytes such as HIV 1&2, Hepatitis B & C virus, Syphilis and HTLV I/II

Biotechnology | 07/07/2020 | By Darshana |  441

The European Commission has granted Orphan Medicinal Product Designation in the EU for MIV-818

Medivir today announced that the European Commission, in accordance with the opinion from the European Medicines Agency (EMA), has granted orphan medicinal product designation in the EU for MIV-818 for the treatment of patients with hepatocellular carcinoma (HCC), the most common type of primary liver cancer

Biotechnology | 05/07/2020 | By Darshana |  372

NPPA fixes retail prices of 14 formulations under DPCO 2013

NPPA has fixed retail prices of 14 formulations under Drugs Prices Control Order (DPCO)- 2013 relating to 76th Authority meeting dated June 22, 2020.

Biotechnology | 03/07/2020 | By Darshana |  641

Selumetinib granted orphan drug designation in Japan for neurofibromatosis type 1

AstraZeneca today announced that selumetinib has been granted orphan drug designation (ODD) in Japan for the treatment of neurofibromatosis type 1 (NF1), a rare and debilitating genetic disease

Biotechnology | 01/07/2020 | By Darshana |  349

'COVAXIN': India's first Covid vaccine gets DGCI's approval for clinical trials

Bharat Biotech, has successfully developed Covaxin, India's 1st vaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech

Biotechnology | 30/06/2020 | By Darshana |  285

Hetero Healthcare set to supply 20,000 vials of generic remdesivir across country

Following the approval of "Covifor", the generic of remdesivir by DCGI, Hetero Healthcare Limited, a group company of Hetero is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each

Biotechnology | 25/06/2020 | By Darshana |  316